Albert Labs International Corp. operates as a research and drug development company. It produces natural pharmaceutical-quality psilocybin medicine to treat cancer-related distress. The firm focuses on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways. The company is headquartered in Burnaby, Canada.